… President Trump’s promise to expand Americans’ access to medical treatment options,” said Acting Attorney General Todd Blanche. “This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information.”🚨Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls
— U.S. Department of Justice (@TheJusticeDept) April 23, 2026
“The Department of Justice is delivering on… pic.twitter.com/MkZbANoZ8l
Expanding Access to Medical Treatment Options
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment